A proposal from the Federal Deposit Insurance Corp. would require the agency to notify Treasury's Financial Crimes ...

Vanflyta® (quizartinib) is now publicly reimbursed in Canada in Quebec, enabling access for adult patients with newly ...

On April 7, 2026, the US Department of the Treasury’s Financial Crimes Enforcement Network (FinCEN) announced a notice of proposed rulemaking ...

Investigators evaluated children with acute lymphoblastic or acute myeloid leukemia to identify racial/ethnic and neighborhood disparities in acute kidney injury.

A survey of 334 compliance professionals across the UK’s regulated sectors by compliance eLearning and software provider, ...

The Court of Appeal has rejected automatic AML misconduct findings, but firms face intensifying regulatory scrutiny and ...

The FDIC, along with the OCC and NCUA, and the Financial Crimes Enforcement Network (FinCEN) have proposed changes to the ...

With new money laundering regulations expected to come into force as early as late June, compliance professionals across ...

The U.S. Food and Drug Administration has approved Taiho Oncology's Inqovi (decitabine and cedazuridine) plus venetoclax for the treatment of adults with newly diagnosed acute myeloid leukemia (AML) ...

CNBC's Jim Cramer called Sellas Life Sciences "a great spec" and gave the biotech stock "two thumbs up" during Mad Money's Lightning Round. ・Investor focus remains on Sellas' Phase 3 Regal trial ...

By Rob Cutler, Managing Director, Nexus AML Financial crime compliance is being reshaped by artificial intelligence faster ...

Regulatory clearance creates an at-home, 28-day cycle option using oral decitabine/cedazuridine on days 1–5 plus venetoclax 400 mg daily after a ramp-up cycle. Efficacy signals in ASCERTAIN-V included ...